• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    HWH International Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits

    11/26/24 5:15:11 PM ET
    $HWH
    Other Pharmaceuticals
    Health Care
    Get the next $HWH alert in real time by email
    false 0001897245 0001897245 2024-11-25 2024-11-25 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    FORM 8-K

     

    CURRENT REPORT

    Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

     

    Date of Report (Date of earliest event reported): November 25, 2024

     

    HWH International Inc.

    (Exact name of registrant as specified in its charter)

     

    Delaware   001-41254   87-3296100

    (State or other jurisdiction

    of incorporation)

     

    (Commission

    File Number)

     

    (I.R.S. Employer

    Identification No.)

     

    4800 Montgomery Lane, Suite 210 Bethesda, MD   20814
    (Address of principal executive offices)   (Zip Code)

     

    Registrant’s telephone number, including area code: (301) 971-3955

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions (see General Instruction A.2. below):

     

    ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
       
    ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
       
    ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
       
    ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

     

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class   Trading Symbol(s)   Name of each exchange on which registered
    Common Stock, $0.0001 par value per share   HWH   The Nasdaq Global Market

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

     

    Emerging growth company ☒

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     

     

     

     

     

     

    Item 1.01 Entry into a Material Definitive Agreement

     

    On November 25, 2024, HWH International Inc. (the “Company”) entered into a stock purchase agreement with Alset Inc. (“Alset”), pursuant to which Alset agreed to purchase 4,411,764 shares of the Company’s common stock (the “Shares”) for a purchase price of $0.68 per share. Alset is the majority shareholder of the Company, and immediately prior to the effectiveness of the stock purchase agreement, Alset directly and through its subsidiaries owned 86.6% of the issued and outstanding shares of HWH common stock.

     

    Following this investment, Alset directly and through its subsidiaries will now own 88.8% of the issued and outstanding shares of HWH common stock.

     

    Our Chairman, Chan Heng Fai, is also the Chairman, Chief Executive Officer and majority stockholder of Alset. In addition, the three other members of our board are also directors of Alset.

     

    Alset’s investment is intended to support the growth and development of HWH. The Company believes that this investment of additional funds into HWH is in the best interests of each of Alset and the Company.

     

    The foregoing description of the Stock Purchase Agreement does not purport to be complete and is qualified in its entirety by reference to the complete text of the Stock Purchase Agreement, a copy of which is filed as Exhibit 10.1 to this Current Report on Form 8-K.

     

    Item 3.02 Unregistered Sales of Equity Securities

     

    The disclosures set forth in Item 1.01 above are hereby incorporated into this Item 3.02 by reference. The 4,411,764 shares of the Company’s common stock sold pursuant to the stock purchase agreement described herein are restricted securities under the Securities Act of 1933, and have been issued in reliance upon the safe harbor provided by Rule 506 of Regulation D.

     

    Item 9.01 Financial Statements and Exhibits

     

    (d) Exhibits.

     

    Exhibit No.   Description
    10.1   Stock Purchase Agreement with Alset Inc. dated November 25, 2024.
    104   Cover Page Interactive Data File (the cover page XBRL tags are embedded within the inline XBRL document).

     

     

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

    Date: November 26, 2024 HWH INTERNATIONAL INC.
         
      By: /s/ Rongguo Wei
      Name: Rongguo Wei
      Title: Chief Financial Officer

     

     

     

    Get the next $HWH alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $HWH

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $HWH
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • HWH International Inc. Announces Reverse Stock Split

      BETHESDA, MD, Feb. 20, 2025 (GLOBE NEWSWIRE) -- HWH International Inc. (the "Company") (NASDAQ:HWH), a purpose-driven lifestyle company, today announced a 1-for-5 reverse stock split of the Company's common stock to become effective at 9:00 a.m. (Eastern Time) on February 24, 2025. The Company's common stock is expected to begin trading on a split-adjusted basis when the markets open on February 24, 2025, under the existing trading symbol "HWH." The reverse stock split is primarily intended to bring the Company into compliance with the minimum bid price requirements for maintaining its listing on the Nasdaq Capital Market. The new CUSIP number following the reverse stock split will be 448

      2/20/25 8:50:00 AM ET
      $HWH
      Other Pharmaceuticals
      Health Care
    • D. Boral Capital Served as Placement Agent to HWH International Inc. (Nasdaq: HWH) in connection with its approximately $1.76 Million Public Offering

      BETHESDA, Md., Jan. 07, 2025 (GLOBE NEWSWIRE) -- HWH International Inc. (the "Company") (NASDAQ:HWH), a purpose-driven lifestyle company, today announced the closing of its public offering (the "Offering") with aggregate gross proceeds to the Company of $1,764,900, prior to deducting fees and other expenses payable by the Company. The Offering consisted of 3,412,500 shares of common stock and 1,000,000 pre-funded warrants to purchase 1,000,000 shares of common stock. Each share of common stock (or pre-funded warrant in lieu thereof) was sold at a purchase price of $0.40 per share (or $0.3999 per pre-funded warrant after reducing $0.0001 attributable to the exercise price of the pre-funded

      1/7/25 11:18:56 AM ET
      $HWH
      Other Pharmaceuticals
      Health Care
    • HWH International Inc. Announces Closing of Approximately $1.76 Million Public Offering at $0.40 per Share

      BETHESDA, MD, Jan. 06, 2025 (GLOBE NEWSWIRE) -- HWH International Inc. (the "Company") (NASDAQ:HWH), a purpose-driven lifestyle company, today announced the closing of its public offering (the "Offering") with aggregate gross proceeds to the Company of $1,764,875, prior to deducting fees and other expenses payable by the Company. The Offering consisted of 3,125,000 shares of common stock and 1,250,000 pre-funded warrants to purchase 1,250,000 shares of common stock. Each share of common stock (or pre-funded warrant in lieu thereof) was sold at a purchase price of $0.40 per share (or $0.3999 per pre-funded warrant after reducing $0.0001 attributable to the exercise price of the pre-funded w

      1/6/25 4:20:00 PM ET
      $HWH
      Other Pharmaceuticals
      Health Care

    $HWH
    Financials

    Live finance-specific insights

    See more
    • HWH International Inc. Acquires Café in South Korea, Unveiling Second Hapi Cafe Outlet

      Bethesda, MD, Feb. 26, 2024 (GLOBE NEWSWIRE) -- HWH International Inc. ("HWH") (NASDAQ:HWH) proudly announces the acquisition of a café in Seocho-gu, South Korea, marking the launch of its second Hapi Cafe outlet in South Korea. HWH is delighted to reveal its latest acquisition of a café nestled in the heart of Seocho-gu, South Korea. This strategic move signifies HWH's dedication to providing unique and welcoming spaces where people can gather to savor food, coffee, and experiences. These cafes are a significant driver of our Health, Wealth, and Happiness vision to offer delicious and nutritious food and beverages to our customers and provide a platform where we can roll out lifestyle pr

      2/26/24 4:15:00 PM ET
      $HWH
      Other Pharmaceuticals
      Health Care

    $HWH
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Chan Heng Fai Ambrose bought $585,000 worth of shares (1,300,000 units at $0.45) (SEC Form 4)

      4 - HWH International Inc. (0001897245) (Issuer)

      12/26/24 5:15:05 PM ET
      $HWH
      Other Pharmaceuticals
      Health Care
    • Director Chan Heng Fai Ambrose bought $3,000,000 worth of shares (4,411,764 units at $0.68) (SEC Form 4)

      4 - HWH International Inc. (0001897245) (Issuer)

      11/26/24 7:12:12 PM ET
      $HWH
      Other Pharmaceuticals
      Health Care
    • Chief Executive Officer Chan Heng Fai Ambrose bought $3,801,758 worth of shares (6,034,537 units at $0.63) (SEC Form 4)

      4 - HWH International Inc. (0001897245) (Issuer)

      9/26/24 9:39:51 PM ET
      $HWH
      Other Pharmaceuticals
      Health Care

    $HWH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4 filed by Executive Chairman Chan Heng Fai Ambrose

      4 - HWH International Inc. (0001897245) (Reporting)

      4/2/25 8:37:43 PM ET
      $HWH
      Other Pharmaceuticals
      Health Care
    • Director Chan Heng Fai Ambrose acquired 69,444 shares (SEC Form 4)

      4 - HWH International Inc. (0001897245) (Issuer)

      3/13/25 4:15:07 PM ET
      $HWH
      Other Pharmaceuticals
      Health Care
    • SEC Form 4 filed by Executive Chairman Chan Heng Fai Ambrose

      4 - HWH International Inc. (0001897245) (Reporting)

      1/28/25 9:36:07 PM ET
      $HWH
      Other Pharmaceuticals
      Health Care

    $HWH
    SEC Filings

    See more
    • SEC Form 10-Q filed by HWH International Inc.

      10-Q - HWH International Inc. (0001897245) (Filer)

      5/15/25 4:16:04 PM ET
      $HWH
      Other Pharmaceuticals
      Health Care
    • SEC Form SCHEDULE 13G filed by HWH International Inc.

      SCHEDULE 13G - HWH International Inc. (0001897245) (Subject)

      5/14/25 4:42:18 PM ET
      $HWH
      Other Pharmaceuticals
      Health Care
    • SEC Form 10-K filed by HWH International Inc.

      10-K - HWH International Inc. (0001897245) (Filer)

      3/31/25 4:05:57 PM ET
      $HWH
      Other Pharmaceuticals
      Health Care

    $HWH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13D/A filed by HWH International Inc.

      SC 13D/A - HWH International Inc. (0001897245) (Subject)

      11/26/24 7:34:11 PM ET
      $HWH
      Other Pharmaceuticals
      Health Care
    • Amendment: SEC Form SC 13D/A filed by HWH International Inc.

      SC 13D/A - HWH International Inc. (0001897245) (Subject)

      11/22/24 5:00:10 PM ET
      $HWH
      Other Pharmaceuticals
      Health Care
    • Amendment: SEC Form SC 13G/A filed by HWH International Inc.

      SC 13G/A - HWH International Inc. (0001897245) (Subject)

      11/14/24 12:40:52 PM ET
      $HWH
      Other Pharmaceuticals
      Health Care